Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Progenika Biopharma

Progenika Biopharma
2000 FOUNDED
M&A STATUS
Corporate LATEST DEAL TYPE
3 FINANCING ROUNDS
2 INVESTMENTS
Description

Operator of a biotechnology company in Spain. The company is engaged in the development, production and commercialization of tools for the diagnosis and prognosis of diseases and for predicting response to drug treatment along with designing vitro diagnostics tests which cover a broad range of clinical needs.

Formerly Known As
Medplant Genetics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • Ibaizabal Bidea, Edificio 504
  • Parque Tecnológico de Bizkaia
  • 48160 Derio
  • Spain

+34 944 00 00 00

Progenika Biopharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Progenika Biopharma‘s full profile, request access.

Request full access to PitchBook

Progenika Biopharma Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 01-Jan-2015 000000000000000000 Diagnostic Equipment
Mecwins Corporate Other Semiconductors
To view this company’s complete investment and acquisition history, request access »

Progenika Biopharma Executive Team (4)

Name Title Board
Seat
Contact
Info
Guillermo Marco-Gardoqui Managing Director & General Manager
María Martinez Finance Director
Corina Junquera Sánchez-Vallejo Ph.D Chief Quality Assurance & Regulatory Affairs Officer
Antonio Martínez Ph.D Chief Executive Officer